Notable Representations, Key Contacts
New York Law Journal, 2020
Guided by our ability to exert leverage at all phases of a case – especially at trial – Weil’s class action litigators combine substantive knowledge with in-depth procedural capabilities to develop tailored litigation strategies to navigate our clients to the earliest possible favorable resolution.
Our competitive advantages include:
- Nationwide, Cross-Disciplinary Coverage. We offer an integrated class action litigation group comprising lawyers with expertise across our top-rated practices and hailing from our eight U.S. offices. This cross-practice and cross-office “one-Firm” approach allows us to undertake a coordinated analysis of our clients’ cases and expertly manage them by bringing to bear the full breadth and strength of the Firm.
- Strong Track Record in Complex Cases. We have an impressive record prosecuting and defending nationwide, multi-state, and multidistrict class action litigations and arbitrations, including some of the largest, bet-the-company cases ever litigated – and tried. Our litigators are regularly involved in cutting-edge cases involving issues of first impression.
- Proven Success at Every Stage. We have achieved successful, business-oriented results for clients at every phase of the class action litigation process in jurisdictions across the country. These include winning at the motion to dismiss stage, defeating class certification, securing summary judgment, prevailing at trial and on appeal, and developing novel and highly favorable settlements. Weil also seizes victories in discovery and expert disputes, as well as in removal, consolidation, and transfer proceedings that are crucial to overcall case strategy.
- Comprehensive Coordinating Counsel Experience. We are regularly called upon by clients to serve as nationwide coordinating counsel in complex multijurisdictional disputes. We excel at fielding multi-disciplinary teams of subject-matter experts that can efficiently address the core issues at the heart of any case, as well as shareholder and regulatory scrutiny, corporate governance questions, restructuring decisions, and public relations and reputational risks.
- Class Action Thought Leadership. We regularly publish assessments of class action developments, contribute articles to leading reviews and journals, and appear as speakers and panelists at national, state and local bar conferences and conventions, and industry meetings.
Weil has decades of experience representing clients – as plaintiffs and defendants – in high-stakes class actions in state and federal courts involving virtually every kind of antitrust/competition and consumer protection allegation, including litigations that arise out of a criminal antitrust investigations and resolutions. Of late, we have played lead roles in some of the largest antitrust class actions, including those involving auto-body repairs, auto parts, and chickens, among others, as well as other cutting-edge claims, such as cases regarding so-called “no-poach agreements” in employment contracts.
Our trial lawyers work hand-in-glove with the group’s regulatory experts – many of whom served in government agencies during formative periods of modern antitrust regulation – to minimize client risk and achieve the most efficient and cost-effective solution.
Key Contacts: John Mastando
We have broad experience litigating class actions involving federal and state financial services regulatory schemes (e.g., Truth In Lending Act (TILA), Equal Credit Opportunity Act (ECOA), Fair Credit Reporting Act (FCRA), Real Estate Settlement Procedure Act (RESPA), and state usury and installment sale statutes), as well as the use of federal and state antitrust and consumer protection statutes, the RICO Act, and other laws of general applicability, to challenge practices involving financial services.
Weil won a dismissal on the pleadings for GE Money Bank (GEMB) before the U.S. District Court for the Eastern District of Missouri in a purported class action seeking statutory damages of $1,000 per alleged violation. Plaintiff claimed that a “prescreened” offer for a line of credit was not a “firm offer of credit” under the FRCA because it allegedly did not disclose certain terms of the offer. Weil successfully argued that the FCRA does not require disclosure of the terms at issue, and demonstrated that the client’s offer letter disclosed more than 20 key terms of the offer and had actual value to the consumer.
Weil also successfully represented GEMB in a purported nationwide class in the U.S. District Court for the Northern District of Illinois alleging violations of the Fair Housing Act and the ECOA. Plaintiffs claimed that GEMB’s alleged “policy” of allowing mortgage brokers the “discretion” to impose charges in connection with mortgage loan origination led to minority borrowers being charged disproportionately higher interest rates and fees. . The plaintiffs also sought to hold GEMB liable for subprime loans originated by another GE subsidiary, that originated billions of dollars in subprime loans and was one of the top ten subprime lenders in the country.
Weil has broad-based expertise defending significant consumer class actions in state and federal courts around the country asserting claims for fraud and violations of other consumer protection statutes. We have particularly strong experience litigating these claims under California, Florida, Illinois, Massachusetts, New York, and Texas statutes, among others, and regularly serve as lead counsel in multi-jurisdictional and nationwide class actions seeking to certify multi-state or national classes.
Weil successfully represented Showtime Networks Inc. in multi-district class action litigation consolidated in the C.D. Cal. relating to the 2015 Manny Pacquiao-Floyd Mayweather boxing match, which was billed as the “Fight of the Century.” Weil secured a strategic early dismissal on behalf of SNI during the MDL consolidation process, avoiding costly additional phases of litigation. Plaintiffs in these cases, including 13 class actions involving Showtime, alleged that Showtime, along with other media networks, the boxers, and their respective promotion companies, deceptively and fraudulently promoted the match as one between two healthy fighters, while allegedly knowing that one of the fighters was injured prior to the start of the fight.
Weil subsequently defended Showtime in a suite of putative class actions arising out of the latest “Fight of The Century” between Floyd Mayweather and UFC star Conor McGregor. Plaintiffs in these cases claim they purchased the pay-per-view match and planned to view it through Showtime’s digital application, but were unable to do so due to Showtime’s alleged insufficient bandwidth and server systems. Weil secured a critical early victory in one of the component cases when a New York federal judge granted Showtime’s motion to compel arbitration of plaintiff’s claims, precluding him from pursuing his claims on behalf of a class. In the subsequent weeks, Weil succeeded in extracting Showtime from every other case in which it was named as a defendant.
Weil’s highly regarded Employment Litigation Practice Group has deep experience litigating class actions in state and federal trial and appellate courts.
We defend clients in thorny class actions involving discrimination claims based on race, age, sex, disability, sexual orientation, retaliation, national origin, and other protected classifications. Of late, our work has revolved around issues that track a number significant societal and cultural developments, including significant gender discrimination and equal pay claims, and claims brought under the Americans with Disabilities Act (ADA) pertaining to, among other things, website accessibility.
We also have extensive experience defending clients in wage and hour class actions involving: classification of employees as employees or independent contractors, full-time or part-time, and exempt or non-exempt; overtime requirements under the Fair Labor Standards Act (FLSA) and comparable state laws; as well as waiting time, meal time, time spent donning and doffing, and pre-shift and post-shift activities; and the Fair Credit Reporting Act (FCRA).
Finally, we also have successfully litigated a number of other class actions involving claims brought under the Worker Adjustment and Retraining Notification Act and Uniformed Services Employment and Reemployment Rights Act.
Weil represented Elite Model Management, one of the world’s most renowned modeling agencies, in a putative collective/class action brought under the FLSA and New York Labor Law (NYLL) alleging that Elite improperly classified its interns as “non-employees.” Initially, the Plaintiff alleged seven causes of action. Shortly after the plaintiff filed her complaint, we convinced plaintiff to drop various causes of action through a strong deficiency letter, thus meaningfully narrowing the scope of the case. We then negotiated a very favorable settlement.
Weil also represented Elite in a massive putative class action that targeted virtually the entire New York modeling industry by challenging the classification of models as independent contractors. The case is the first of its kind in New York State, and has the potential to alter the landscape of the entire modeling industry. In May 2017, Weil obtained a huge victory (which no other defendant achieved) when the court granted Elite’s motion to dismiss almost in its entirety, leaving only a single individual claim against Elite asserted by one named plaintiff. Leveraging the favorable court ruling, Weil deployed a unique strategy involving a “notice of tender” under the CPLR to force plaintiffs’ counsel to accept the offer and dismiss the entire class case against Elite with prejudice. Elite was the only defendant to obtain a complete dismissal from the case.
Weil represented Forest Laboratories, Inc. and Forest Pharmaceuticals, Inc. (together, “Forest”), in a putative gender class and collective action brought on behalf of eleven former sales representatives. Weil successfully narrowed the scope of the case through a motion to dismiss and/or strike, which resulted in the dismissal of several individual claims and a significant narrowing of the putative Title VII class period, and subsequently won the denial of plaintiffs’ motion for equitable tolling of the statute of limitations for potential collective action members’ claims. The matter is a bellwether case due to, among other reasons, the more nuanced gender claims it alleges including family responsibility discrimination, “sex plus” discrimination, “sex stereotyping,” pregnancy-related issues, and compensation disparities based on neutral pay practices.
Weil was retained by Tuesday Morning, Inc. (TMI), a leading national retailer, to replace another prominent law firm in a California state court wage and hour class action following a series of adverse rulings – including the granting of Plaintiffs’ motion for class certification and the denial of Defendant’s subsequent motions for decertification and summary judgment. Among other California wage and hour claims, plaintiffs challenged TMI’s practice of providing “on-duty” meal periods to its California Senior Sales Associates, an issue that is not frequently litigated and on which there is limited and ambiguous legal authority. The certified class included current and former employees of all 87 of TMI’s California-based stores. Following our retention as counsel, we negotiated an extremely favorable resolution for our client by, among other things, developing and marshalling the discovery record in a manner that evinced compliance on TMI’s part with the Division of Labor Standards and Enforcement’s standards for “on duty meal periods” and virtually eliminating any Private Attorneys General Act penalty exposure through a novel but substantiated interpretation of that statute.
Weil was subsequently retained to defend another California wage and hour class action, Christie. This case involved putative class claims for failure to pay wages without discount in violation of California Labor Code Section 212 on behalf of TMI’s entire California workforce, based on TMI’s use of payroll debit cards, failure to provide meal and rest periods, and failure to pay hourly wages, as well as other derivative California wage-based claims. Plaintiff based her pay card claims on her allegation that TMI employees incurred fees when attempting to access their wages via the pay card program that TMI offered to its employees as an alternative to direct deposit. After removing the case to the U.S. District Court for the Central District of California, Weil obtained a rare dismissal of the entire lawsuit with prejudice. Plaintiff then filed an appeal with the Ninth Circuit, but before TMI was required to file its response, the parties reached a settlement whereby the matter was resolved on an individual basis for a nominal sum. Weil is one of only a small handful of firms in the country that has obtained an early dismissal on the pleadings of such pay card claims.
Following the Christie matter, Weil was again retained by TMI in another putative California wage and hour class action in the Northern District of California involving nearly 4,000 potential class members (McMahon). Plaintiff’s counsel, a leading national wage and hour class action attorney, asserted class claims for failure to provide rest breaks, failure to timely pay all final wages, violation of California’s unfair competition law, and civil penalties under the Private Attorneys General Act (PAGA), seeking to recover substantial eight-figure damages. After an attempted mediation, Weil won a key dispositive motion where the court rejected plaintiff’s attempt to expand the case significantly, and then secured during a deposition of the lead plaintiff numerous fatal admissions to her class claims, which laid the groundwork for a very favorable settlement. This case also involved a ground breaking ruling on how PAGA settlement funds should be allocated to the class versus the state of California.
Weil also won an early and complete dismissal on a motion to dismiss of another California-based putative class action brought against TMI involving claims under the FCRA and the California corollary background and credit check statutes.
Key Contact: Nicholas Pappas
Weil has extensive experience handling high-profile ERISA class actions involving claims for breach of fiduciary duty and improper benefit denials and reductions. We routinely deal with complex issues that require coordination of multiple disciplines – including bankruptcy, tax, labor and foreign law – to align legal solutions with business objectives, and our Firm’s employment lawyers bring a broad expertise in all aspects of employee benefits and executive compensation law.
Our lawyers have achieved victories that established important precedents in the nation’s highest court and in cases affecting industry-wide practices, including health care, financial services, and professional services. We have represented numerous clients in crisis situations, including in early, precedent-setting “stock drop” litigations and in claims brought by the Pension Benefit Guaranty Corporation.
Weil defended AIG and certain current and former employees in a putative class action under ERISA on behalf of participants in certain 401(k) plans sponsored by AIG (the Plans) during the period August 7, 2007 through May 1, 2009 and whose participant accounts included shares of AIG’s Stock Fund. Plaintiffs alleged, among other things, that the defendants breached their fiduciary responsibilities to the Plans’ participants and their beneficiaries under ERISA by continuing to offer the AIG Stock Fund as an investment option in the Plans after it allegedly became imprudent to do so; they claimed that the purported violations caused hundreds of millions of dollars in damages. The alleged ERISA violations related to, among other things, the defendants’ purported failure to monitor and/or disclose unrealized market valuation losses on AIG Financial Product’s super senior credit default swap portfolio. In light of the U.S. Supreme Court’s decision in Fifth Third Bancorp (U.S. June 25, 2014), which rejected the presumption of prudence in favor of ERISA fiduciaries that many courts had previously applied, the Court denied defendants’ motion to dismiss without prejudice to renewal of defendants’ motions on other grounds besides the presumption of prudence. The Court’s order required the parties to meet and confer concerning the impact of Fifth Third Bancorp and the possibility of settlement. The parties subsequently accepted a mediator’s proposal to settle the class action for $40 million – a fraction of the more than $300 million value that the plaintiffs sought – and the court later approved.
Weil served as lead counsel for UnitedHealth in a nationwide putative class action in Arizona federal court brought by a physical therapy provider who purported to have received an assignment of the rights and benefits of at least 60 plan participants and/or beneficiaries, two individuals treated by the plaintiff provider, and the Arizona Chiropractic Society. Weil also represented 35 of the 45 employer-sponsored health plans named as co-defendants. The Ninth Circuit, in its November 5, 2014 opinion reviewing the district court’s grant of summary judgment in defendants’ favor on all claims, expressed its views on several distinct issues likely to recur in ERISA lawsuits throughout the country, including assignments of benefits, constitutional standing, the enforceability of limitations periods stated in the plan, and whether a claims administrator of a self-funded ERISA plan may be sued for benefits. Following the Ninth Circuit’s decision – which affirmed in part, reversed in part, vacated in part, and remanded – defendants petitioned the U.S. Supreme Court for a writ of certiorari, which was subsequently denied. Defendants then again moved for partial summary judgment, raising several arguments including constitutional and statutory standing, Arizona’s statute of limitations for ERISA benefits claims, the enforceability of limitations periods stated in different plans, and anti-assignment provisions precluding a provider from filing a civil suit on behalf of a participant. The court granted in part and denied in part defendants’ motion, agreeing with the defendants’ arguments regarding the proper statute of limitations and the enforceability of anti-assignment provisions, and considerably narrowing the case. In January 2019, the Court granted the parties’ joint motion for conditional certification of settlement class, preliminary approval of settlement agreement, and approval of form and content of notice to settlement class members. The settlement included a payment to a settlement class of $1.475 million, a fraction of the initial amount sought by the putative class. The court entered its judgment of dismissal in August 2019.
Weil represented the University of Miami (UM) in a putative ERISA class action filed in the U.S. District Court for the Southern District of Florida by a former member of the “voluntary faculty” at the University of Miami School of Medicine.
The plaintiffs asserted a single claim against UM under ERISA § 502(a)(3), claiming that UM breached its fiduciary duties by failing to extend to them the opportunity to participate in various retirement and welfare benefit plans offered to regular employees, including the plans for health care insurance, dental insurance, vision insurance, long term disability insurance, short term disability insurance, long term care insurance, life insurance, accident insurance, flexible spending accounts, tuition remission, and legal assistance.
Weil filed a motion to dismiss the plaintiff’s complaint for failure to state a claim, arguing, among other things, that voluntary faculty members were not defined as eligible “participants” under the express terms of the plans and that the plaintiffs could not seek monetary relief for unpaid benefits under ERISA § 502(a)(3). The parties reached a settlement, and the case was dismissed with prejudice in December 2017.
Key Contact: David Yohai
Weil has in-depth knowledge of the insurance and reinsurance business and the complex issues faced in the insurance industry. Our powerful blend of litigation and arbitration experience brings expertise to all sides of complex disputes, including successfully defending clients against private, government, and class action suits and representing plaintiffs in major cases of first impression.
For many years, Weil has served as lead counsel to Farmers Insurance Exchange and its affiliates in defense of a number of significant class actions. Recent examples include:
- Weil achieved a significant appellate victory for Farmers Insurance Exchange and Mid-Century Insurance Company in the U.S. Court of Appeals for the Tenth Circuit. The court affirmed the dismissal of a class action in which plaintiffs challenged a time limitation in Farmers’ automobile insurance policies.
- Weil successfully represented Farmers Insurance Company in a putative class action alleging that the company and a number of affiliates wrongfully adjusted and reduced claims for medical payment benefits. The court denied plaintiffs’ motion for class certification, finding that individual issues concerning what was “reasonable” predominated throughout the case, and held that the class representatives were atypical and inadequate to represent the proposed class.
- Weil successfully represented Farmers Insurance Exchange in a putative nationwide class action alleging that Farmers Insurance Exchange breached its insurance agreements by using fee review computer software to improperly deny coverage for the class’ reasonable medical expenses. The court dismissed plaintiffs’ complaint, and the Third Circuit later affirmed, and denied plaintiffs’ motion for rehearing or rehearing en banc.
Weil represented Genworth in a purported nationwide class action filed in the U.S. District Court for the Northern District of Ohio related to the optional inflation rider on Genworth long-term care insurance policies. The named plaintiff, the estate of a deceased beneficiary, alleged it was due additional benefits under the beneficiary’s long-term care insurance policy. Weil filed a motion to transfer the action to Connecticut, as well as a motion to dismiss the complaint. Following the filing of these motions, the plaintiff agreed to voluntarily dismiss the complaint.
Weil obtained summary judgment for Genworth in a class action in federal court in New Jersey asserting claims for breach of contract in connection with premium rates for long-term care insurance policies.
Weil also defended two nationwide insurance class actions in New Mexico state court asserting claims for breach of contract, failure to disclose and violations of state unfair and deceptive trade practices statutes.
Weil’s award-winning national Product Liability & Mass Tort practice – recognized as a Product Liability Litigation Department of the Year finalist by The American Lawyer in 2018 – has played lead and coordinating counsel roles in some of the country’s most significant and well- publicized product defect class actions and multi-district litigation. Weil offers unparalleled trial court experience before judges and juries in products and mass tort cases, as well as renowned mastery of issues of causation, MDL procedure, and class certification, which are of paramount importance in the product context. As a result, we offer clients considerable leverage in litigating these cases that helps us achieve favorable pre-trial resolutions and settlements and reduce financial and reputational risks.
In July 2019—two years after winning summary judgment in a predecessor case—Weil achieved another significant victory on behalf of Dometic Corporation in the U.S. District Court for the Southern District of Florida, after U.S. District Court Judge Robert N. Scola denied Plaintiffs’ motion for class certification and dismissed the consumer class action in its entirety.
Dometic is a leading manufacturer of gas absorption refrigerators, which are uniquely suited for use in recreational vehicles. The lawsuit, like its predecessor, alleged that the cooling units in various models of the company’s gas absorption refrigerators purportedly contained a latent defect. Plaintiffs’ motion for class certification proposed ascertaining a class through Dometic’s “sales and warranty registration records,” notifications that were sent in connection with a product recall years ago, and self-identification through affidavits. The court rejected each and every one of these arguments, ruling that plaintiffs’ proposed classes are not ascertainable and therefore cannot be certified under Rule 23. The court specifically noted plaintiffs’ failure to describe how any of their proposed methods would work, contrasting this lack of evidence with the proof put forward by Dometic to the effect that none of these methods would be feasible.
This win follows another important victory that Weil achieved for Dometic in the same court in July 2017, when Judge Scola granted summary judgment and dismissed a putative class action in its entirety.
Weil successfully represented Nortek Global HVAC, LLC, a leading manufacturer of heating, ventilation and air conditioning equipment, in several putative class actions in Florida and Tennessee federal courts alleging that Nortek failed to disclose defects in its air conditioning equipment. Weil obtained the denial of plaintiffs’ motion for class certification in the Florida case, as well as the dismissal of all claims, with prejudice, in the Tennessee case.
Weil successfully represented as lead counsel Procter & Gamble in the high-profile multi-district litigation, In re Denture Cream Products Liability Litigation, in which more than 150 plaintiffs alleged that they were injured through their use of the popular denture cream, Fixodent. In this action, Weil won numerous motions to exclude plaintiffs’ general causation experts, and secured affirmation by the U.S. Court of Appeals for the Eleventh Circuit on two separate occasions. Ultimately, after these victories, P&G moved for summary judgment in approximately six cases in which plaintiffs argued that they were not subject to the district court’s prior Daubert rulings. The district court granted summary judgment in all of these cases, bringing seven years of litigation to a close on October 25, 2016. The Eleventh Circuit dismissed subsequent appeals by five of these six plaintiffs in November 2016 and January 2017.
Weil served as lead counsel in the defense of Toyobo, a major Japanese fiber manufacturer, in class action suits, multiple personal injury suits, as well as claims by multiple state attorneys general, the U.S. Department of Justice, and foreign states relating to the performance of Toyobo’s Zylon fiber in bullet-resistant vests used by thousands of law enforcement agencies worldwide. In connection with class actions, the Weil litigation team aggressively defended Toyobo and positioned it to favorably settle the class claims brought on behalf of individuals, municipalities, and police agencies who wore or paid for the bullet-resistant vests.
Weil’s Securities Litigation practice has defended issuers, directors, and corporate executives against virtually every kind of securities claim brought as a class action. Our litigators have experience defending clients against alleged violations of the Securities and Exchange Act of 1934, the Securities Act of 1933, and state law fiduciary duties resulting from, among others, the recent financial crisis, changes in corporate control, allegedly misleading investor communications, stock and/or earnings manipulation, accounting irregularities, insider fraud and misappropriation, market timing, late trading, and stock options dating and granting processes.
Weil’s practice also has significant experience in class actions and derivative litigation in the context of mergers & acquisitions and other change-of-control transactions brought by shareholder and/or derivative plaintiffs seeking to block and/or recover damages for merger activity.
Weil served as lead counsel nationwide for AIG in shareholder class, derivative and ERISA actions arising out of AIG’s billions of dollars of subprime-related losses and its financial rescue by the U.S. government. Among our victories, Weil secured the widely noted dismissal of a shareholder derivative action alleging mismanagement by AIG directors and officers, and more recently obtained the dismissal of all derivative claims asserted in the lawsuit brought by Hank Greenberg’s company Starr International against the United States for more than $50 billion arising out of AIG’s bailout during the financial crisis.
Weil negotiated a favorable settlement of the shareholder class action, and we subsequently have litigated a number of “opt-out” suits.
For many years, Weil has lead the representation of Archstone in connection with nationwide securities litigation and arbitrations arising from one of the largest REIT deals in history, the 2007 $22 billion acquisition of Archstone-Smith Trust by affiliates of Lehman Brothers and Tishman Speyer Development Corporation. The $4 billion class action was originally filed in 2007 by investors in the REIT, who claimed that the structure of the acquisition diluted their interests and cost them billions of dollars in tax liability and/or inferior securities.
After more than a decade of litigation, Weil won a complete victory in August 2017 in the U.S. District Court for the District of Colorado when the Court granted summary judgment on every count as to each of the more than 20 defendants, including Lehman Brothers, Tishman-Speyer, Equity Residential, the Archstone-Smith REIT and the indemnifying parties. Weil represented all of the defendants. As a result of this decision, the trial that had been scheduled for January 2018 has been vacated, and all counts against all defendants have been dismissed. In December 2018, the Tenth Circuit affirmed the summary judgment decision in a thorough opinion.
Weil represented Sanofi, the global pharmaceutical company, and its former CEO in a consolidated securities fraud class action brought by a putative class of investors in Sanofi American Depositary Shares. Plaintiffs principally alleged that Sanofi’s public disclosures were materially misleading because they failed to disclose that growth in Sanofi’s diabetes franchise was boosted by alleged illicit promotional activities. In January 2016, the U.S. District Court for the Southern District of New York granted the defendants’ motion to dismiss the complaint in its entirety.
Weil also represented Sanofi, its wholly-owned subsidiary Genzyme Corporation and certain of their senior executives in federal securities class and individual actions brought by holders of contingent value rights issued in connection with Sanofi’s 2011 acquisition of Genzyme, relating to the development of Genzyme’s multiple sclerosis drug, Lemtrada™. In a January 2015 Opinion and Order, the U.S. District Court for the Southern District of New York granted the defendants’ motions to dismiss the cases in their entirety and disposed of all federal claims with prejudice. Subsequently, in March 2016, the Second Circuit affirmed the dismissal in a landmark opinion that is the first by the Second Circuit to address the U.S. Supreme Court’s seminal Omnicare decision, which articulated the standard for securities fraud liability for allegedly misleading statements of opinion.
Weil has represented legacy Willis (pre-dating its 2016 “merger of equals” with Towers Watson) in connection with approximately 15 securities class and individual actions arising out of the heavily publicized, $8 billion Ponzi scheme orchestrated by R. Allen Stanford and his Houston-based Stanford Financial Group. The complaints in these actions, originally filed in various state and federal courts across the country and centralized in the U.S. District Court for the Northern District of Texas by the Judicial Panel on Multi-District Litigation, generally allege that Willis and other defendants aided Stanford’s fraud.
In August 2017, following motion practice, limited discovery, and appellate proceedings before the U.S. Court of Appeals for the Fifth Circuit and the U.S. Supreme Court, a Texas federal judge approved a settlement by Willis that favorably resolved the litigation. In 2019, the U.S. Court of Appeals for the Fifth Circuit affirmed the settlement.
Weil is ranked among the top 10 firms nationally for Consumer Class Actions.
Chambers USA 2020
Clients note that "Weil has a very deep bench. From top to bottom, their lawyers are smart, talented, responsive, hardworking and reliable."
Chambers USA, 2020
Weil is ranked among the top 5 firms nationally for Product Liability, Mass Tort and Class Action – Defense: Consumer Products.
Legal 500 US 2020
Sources note that “the team has extraordinary depth of experience and strategic judgment” and is “invaluable in assessing risk and managing complex and difficult matters.”
Legal 500 US 2020
Weil and its litigators have received extensive nationwide recognition from Law360 for our work in the class action arena:
- 2019 Class Action Practice Group of the Year
- 2018 Class Action Rising Star (Eric Hochstadt)
- 2017 Class Action MVP (Ed Soto)
- 2017 Class Action Rising Star (David Singh)
- 2015 Class Action Practice Group of the Year
- 2012 Class Action MVP (David Lender)
Weil litigators “distinguish themselves by the sheer variety of class action categories they tackle…”
Weil again proved its “class action prowess” through “strategic use of data” and other “standout legal maneuver[s].”